title: Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number.
authors.affiliation: Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: Harry W
authors.initials: HW
authors.lastname: Herr
mesh_terms: D002291:Carcinoma, Papillary / Q000473:pathology* / Q000628:therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000628:therapy; D012449:Safety; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000628:therapy